These results fit a model whereby these metabolic processes sustain lymphoma cell growth and proliferation, which outcompetes the apoptotic phenotype that arises when the reducing capacity generated via oxPPP-mediated NADPH production becomes overwhelmed by the oxidative byproducts of other pathways engaged upon supraphysiological Myc overexpression (Fig. 1O). This evidence concerns the gene MYC and lymphoma.